Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  DaVita    DVA

DAVITA

(DVA)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/10/2019 09/11/2019 09/12/2019 09/13/2019 09/16/2019 Date
61.66(c) 59.81(c) 60.3(c) 61.86(c) 63.28(c) Last
2 613 562 2 026 455 2 875 828 3 611 025 2 963 643 Volume
+0.80% -3.00% +0.82% +2.59% +2.30% Change
More quotes
Financials (USD)
Sales 2019 11 350 M
EBIT 2019 1 674 M
Net income 2019 745 M
Debt 2019 6 790 M
Yield 2019 -
Sales 2020 11 581 M
EBIT 2020 1 589 M
Net income 2020 696 M
Debt 2020 6 974 M
Yield 2020 -
P/E ratio 2019 12,9x
P/E ratio 2020 12,1x
EV / Sales2019 1,37x
EV / Sales2020 1,36x
Capitalization 8 762 M
More Financials
Company
DaVita specializes in providing dialysis services. Net sales (including intragroup) break down by activity as follows: - supply of dialysis services (93.5%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2018, services are insured... 
More about the company
Surperformance© ratings of DaVita
Trading Rating : Investor Rating :
More Ratings
Latest news on DAVITA
08/27DAVITA INC. : Schedules Capital Markets Day for September 10, 2019
PR
08/22DAVITA : Announces Final Results Of Self-Tender Offer
PR
08/21A FORCE FOR CHANGE : DaVita Continues to Prioritize Environmental Sustainability
PU
08/19DAVITA : Announces Preliminary Results Of Self-Tender Offer
PR
08/14DAVITA INC. : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
08/12DAVITA : Announces New Senior Secured Credit Agreement
PR
08/02DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/01DAVITA INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
08/01DAVITA INC. : 2nd Quarter 2019 Results
PR
07/30DAVITA : Innovation in Home Care Delivery Improves the Quality of Life for More ..
PR
More news
Analyst Recommendations on DAVITA
More recommendations
Sector news : Healthcare Facilities & Services - NEC
09/16Opioid plaintiffs fight bid to disqualify U.S. judge before trial
RE
09/15Fresenius drops possible sale of blood transfusion unit - spokesman
RE
09/11Surescripts in Dispute With ReMy Health -CNBC
DJ
09/09Walgreens Boots Alliance on Pace for Largest Percent Increase in Over a Year ..
DJ
09/06ALPHABET, MATCH GROUP, CVS : Stocks That Defined The Week
DJ
More sector news : Healthcare Facilities & Services - NEC
Chart DAVITA
Duration : Period :
DaVita Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 67,08  $
Last Close Price 63,28  $
Spread / Highest target 23,3%
Spread / Average Target 6,00%
Spread / Lowest Target -5,18%
EPS Revisions
Managers
NameTitle
Kent J. Thiry Chairman & Chief Executive Officer
Atul Mathur Executive Vice President-Global Operations
Joel Ackerman Chief Financial Officer
George R. Aronoff Chief Medical Officer
Peter Thacher Grauer Lead Independent Non-Executive Director
Sector and Competitors